Jenavalve Technology, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$656Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
208clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Nicholas Amoroso | Pawleys Island, SC | Interventional Cardiology | $177,538.18 |
| Wayne Weaver | Detroit, MI | Cardiovascular Disease | $72,924.07 |
| Mark Gorman | Scarborough, ME | Vascular Neurology | $52,415.74 |
| Steven Bailey | Shreveport, LA | Interventional Cardiology | $51,697.64 |
| Torsten Vahl | New York, NY | Interventional Cardiology | $39,286.40 |
| Firas Zahr | Portland, OR | Cardiovascular Disease | $39,077.47 |
| Andrea Carpenter | San Antonio, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $27,041.67 |
| Frederick Grover | Aurora, CO | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $24,246.63 |
| David Daniels | Burlingame, CA | Interventional Cardiology | $21,730.61 |
| Jubin Joseph | Los Angeles, CA | Interventional Cardiology | $19,748.46 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.